comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery A network meta-analysis backed weight-loss benefits with several GLP-1 receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Among patients who were eligible

Citing the KFF poll, Denisse Colindres, senior manager of nutrition communication for North America at BENEO, Parsippany, N.J., says this exemplifies the staying power of GLP-1s

Rotate injection sites regularly to reduce irritation

Weight Loss Timeline: First Month to Three Months Measurable weight loss typically emerges between weeks 2 and 4 of consistent GLP-1 therapy, though the first week usually shows minimal scale change despite reduced hunger

Benefits for Specific Populations Semaglutides benefits extend across several patient populations: Diabetic Patients: For individuals with Type 2 diabetes, Semaglutide can address both blood sugar levels and kidney health

It depends on the amount of weight you are wanting to lose and the amount of time it takes for you to achieve your goal, each individual patient is different